Statistics from Altmetric.com
Q How effective is aripiprazole for preventing relapse in people with bipolar I disorder who have recently been stabilised with aripiprazole after experiencing a manic or mixed episode?
Randomised controlled trial.
Follow up period:
Twenty six weeks (treatment period).
Seventy six centres, Mexico, US and Argentina; enrolment: March 2000 to June 2003.
161 adults with a manic or mixed episode of DSM-IV bipolar I disorder whose symptoms stabilised after 6–18 weeks open-label 15 or 30 mg/day aripiprazole (lower dose used if higher dose not tolerated; stabilisation defined as total Young Mania Rating Scale score ⩽10 and Montgomery-Asberg Depression Rating Scale score ⩽13 in four consecutive visits over 6 weeks). Exclusions: cognitive disorder, schizophrenia, or schizoaffective disorder; psychotic symptoms explained by substance abuse or another medical disorder; unresponsive to clozapine; psychoactive or substance use disorder; allergy or hypersensitivity to aripiprazole or quinolones; seizure disorder or neuroleptic malignant …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.